Treatment
Bryomixol is a source of additional Cell Energy, providing a reenergizing force with the final object of maintaining cell viability and function.
Bryomixol is a complex compound formed by the essences of the plants and minerals found in forests and deserts of the world, which are greatly diluted, energetically stored in sterile water, and introduced in tiny amounts into the human body, sublingually, by inhalation, and/or by intra muscular and/or intravenous injections.
Bryomixol treatment is absolutely natural, without toxic effects or contraindications. It is based on naturally enhancing the cancer patient’s own immune response, through stimulation of the NK (Natural Killer) cells responsible for our immune defenses. Bryomixol treatment also rapidly activates the alternative cellular energy (ACE) mechanism, the Alternative Cellular Energy Path, which is suppressed in whole or in part by the disease itself or traditional treatments such as chemotherapy, radiotherapy, or surgery.
We recommend starting with Bryomixol as soon as possible upon diagnosis of the disease. Bryomixol treatment should ideally be received before, during, and after classic therapeutic procedures for cancer (chemotherapy, radiotherapy, and surgery). All these methods are immunosuppressive in one way or another.
In general, our Bryomixol treatment has three phases: |
| Phase One: |
| Attack Phase, consisting of two weeks of intense treatment at our specialized center in Central America. There, the patient is fully evaluated at the clinical level by our physician specialists. Using the most modern diagnostic techniques of traditional medicine, the physician specialists establish a specific treatment protocol for the initial attack with Bryomixol, customized for each particular case. The patient is placed under observation, with personalized care during these initial days, and an evaluation is made of each patient’s therapeutic response to the Bryomixol treatment. |
| Phase Two: |
| Once this initial-attack treatment is completed, the patient
commences the second phase of Bryomixol therapy upon returning
home. Under the supervision of his local family doctor, the patient
will be treated with a specific Bryomixol protocol for 90
days. In this second phase, the patient can and should combine the traditional treatments recommended by his oncologist with Bryomixol treatment, following the specific indications for each particular case. |
| Phase Three: |
| At the end of 90 days, Phase Three or the “maintenance phase”
of Bryomixol treatment is commenced. This phase varies in duration
for each particular case, based on the new evaluation of the
patient, recommended at the end of the 90-day treatment. This new medical evaluation can take place at our medical center in Central America (it will take a few days). Alternatively, it can be conducted by the patient’s original doctor or the local physicians of our group who are familiar with Bryomixol treatment in each country. |